Calidi Biotherapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
Ognian Anguelov Gavrilov has reduced his beneficial ownership in Calidi Biotherapeutics, Inc. to 0.3% of outstanding common stock.